World's Best Scientists 2026 revealed!
Gustav Gaudernack

Gustav Gaudernack

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 64 2934 2708 17 12 263 14841

Gustav Gaudernack publications per year

The chart shows the history of publications by Gustav Gaudernack between 1971 and 2023, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Gustav Gaudernack published across 53 years, from 1971 to 2023, averaging 5.7 papers a year. Output peaked at 26 publications in 2023. 29 of the 302 publications appeared in the last two years.

No. of publications
5 10 15 20 25
Bar chart. Horizontal axis: year, 1971 to 2023. Vertical axis: number of publications, 0 to 26. Peak 26 publications in 2023. 1971: 1 publication 1972: 0 publications 1973: 1 publication 1974: 1 publication 1975: 1 publication 1976: 0 publications 1977: 2 publications 1978: 0 publications 1979: 1 publication 1980: 2 publications 1981: 1 publication 1982: 4 publications 1983: 2 publications 1984: 6 publications 1985: 6 publications 1986: 3 publications 1987: 7 publications 1988: 15 publications 1989: 17 publications 1990: 7 publications 1991: 3 publications 1992: 7 publications 1993: 4 publications 1994: 11 publications 1995: 9 publications 1996: 8 publications 1997: 6 publications 1998: 5 publications 1999: 5 publications 2000: 2 publications 2001: 13 publications 2002: 6 publications 2003: 6 publications 2004: 6 publications 2005: 7 publications 2006: 9 publications 2007: 7 publications 2008: 7 publications 2009: 7 publications 2010: 5 publications 2011: 7 publications 2012: 4 publications 2013: 6 publications 2014: 8 publications 2015: 5 publications 2016: 9 publications 2017: 6 publications 2018: 3 publications 2019: 5 publications 2020: 4 publications 2021: 6 publications 2022: 3 publications 2023: 26 publications
1971 2023

302 publications in total across all disciplines

View publications per year as a table
Gustav Gaudernack: publications per year, 1971 to 2023
Year Publications
1971 1
1972 0
1973 1
1974 1
1975 1
1976 0
1977 2
1978 0
1979 1
1980 2
1981 1
1982 4
1983 2
1984 6
1985 6
1986 3
1987 7
1988 15
1989 17
1990 7
1991 3
1992 7
1993 4
1994 11
1995 9
1996 8
1997 6
1998 5
1999 5
2000 2
2001 13
2002 6
2003 6
2004 6
2005 7
2006 9
2007 7
2008 7
2009 7
2010 5
2011 7
2012 4
2013 6
2014 8
2015 5
2016 9
2017 6
2018 3
2019 5
2020 4
2021 6
2022 3
2023 26
Total 302
Download as CSV

Gustav Gaudernack publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gustav Gaudernack sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 262–271 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 263 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116 263
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Gustav Gaudernack D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gustav Gaudernack sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 64–65 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173 64
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Gustav Gaudernack is affiliated with Ultimovacs in Norway, focusing on research in medicine, immunology, and molecular biology. Their primary fields of study are Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology, with specific subfields including Oncology, Immunology, Biotechnology, Molecular Biology, and Biomedical Engineering.

The scientist's research extensively covers topics such as Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Cancer Research and Treatments, Virus-based gene therapy research, vaccines and immunoinformatics approaches, and T-cell and B-cell Immunology.

Gustav Gaudernack has published several papers in a variety of scientific journals. Notable recent works include:

  • "Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention," 2020, Toxicology Reports
  • "Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer," 2020, Frontiers in Immunology
  • "Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial," 2021, Frontiers in Immunology
  • "Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential," 2021, Frontiers in Immunology
  • "Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials," 2022, Journal for ImmunoTherapy of Cancer

Their frequent co-authors include Else Marit Inderberg, Espen B. Ellingsen, Tormod Kyrre Guren, Eivind Hovig, and Sara M. Mangsbo. These collaborations have contributed to publications in prominent venues such as Frontiers in Immunology, Toxicology Reports, Nature Communications, Journal for ImmunoTherapy of Cancer, and Molecular Therapy.

Gustav Gaudernack's work in cancer immunotherapy includes both clinical and molecular research focusing on telomerase-based vaccines, immune responses, and therapeutic approaches integrating novel immunotherapeutic agents. The scope of the research addresses long-term patient outcomes, vaccine efficacy, and mechanisms underlying immune activation and tolerance in cancer and infectious diseases.

Best Publications

  • Therapeutic vaccines for cancer: an overview of clinical trials

    Ignacio Melero;Gustav Gaudernack;Winald Gerritsen;Christoph Huber

  • Photochemical internalization: a novel technology for delivery of macromolecules into cytosol.

    Kristian Berg;Pål Kristian Selbo;Lina Prasmickaite;Torunn E. Tjelle

  • Intradermal ras peptide vaccination with granulocyte‐macrophage colony‐stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma

    Marianne K. Gjertsen;Trond Buanes;Arne R. Rosseland;Arne Bakka

  • Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study.

    S. L. Bernhardt;M. K. Gjertsen;S. Trachsel;M. Møller

  • Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.

    Einar Osland Vik-Mo;Marta Nyakas;Birthe Viftrup Mikkelsen;Birthe Viftrup Mikkelsen;Morten Carstens Moe

  • Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

    Paal F. Brunsvig;Steinar Aamdal;Marianne K. Gjertsen;Gunnar Kvalheim

  • Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer

    Ingvil Sæterdal;Jens Bjørheim;Kari Lislerud;Marianne K. Gjertsen

  • HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique.

    Frode Vartdal;Gustav Gaudernack;Steinar Funderud;Anne Bratlie

  • In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen.

    Gilla Kaplan;Gustav Gaudernack

  • Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.

    J. A. Kyte;L. Mu;Steinar Aamdal;Gunnar Kvalheim

  • Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

    M.K. Gjertsen;J. Breivik;I. Saeterdal;E. Thorsby

  • CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells: Evidence for a soluble inhibitor

    Jan E. Brinchmann;Gustav Gaudernack;Frode Vartdal

  • Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation.

    Marianne K. Gjertsen;Jens Bjørheim;Ingvil Saeterdal;June Helen Myklebust

  • Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras.

    Synne Wedén;Synne Wedén;Marianne Klemp;Marianne Klemp;Ivar P. Gladhaug;Ivar P. Gladhaug;Mona Møller

  • Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial.

    Paal Fr. Brunsvig;Jon Amund Kyte;Christian Kersten;Stein Sundstrøm

  • Sialomucin CD34 is the major L-selectin ligand in human tonsil high endothelial venules.

    Kamal D. Puri;Erik B. Finger;Gustav Gaudernack;Timothy A. Springer

  • mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT)

    Stein Sæbøe-Larssen;Ellen Fossberg;Gustav Gaudernack

  • Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients

    Jon Amund Kyte;Gustav Gaudernack;Svein Dueland;Sissel Trachsel

  • Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.

    Ana B. del Campo;Jon Amund Kyte;Javier Carretero;Svitlana Zinchencko

  • Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines

    Ping Wang;Quanli Gao;Zhenhe Suo;Zhenhe Suo;Else Munthe

  • Isolation of pure functionally active CD8+ T cells positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres

    Gustav Gaudernack;Torbjørn Leivestad;John Ugelstad;Erik Thorsby

Frequent Co-Authors

Gunnar Kvalheim
Gunnar Kvalheim Oslo University Hospital
Erik Thorsby
Erik Thorsby Oslo University Hospital
Anne Spurkland
Anne Spurkland University of Oslo
Erlend B. Smeland
Erlend B. Smeland Oslo University Hospital
Ludvig M. Sollid
Ludvig M. Sollid Oslo University Hospital
Knut E.A. Lundin
Knut E.A. Lundin University of Oslo
Øystein Fodstad
Øystein Fodstad Oslo University Hospital
Per thor Straten
Per thor Straten University of Copenhagen
Sophie D. Fosså
Sophie D. Fosså Oslo University Hospital
Anne Lise Børresen-Dale
Anne Lise Børresen-Dale Oslo University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring immunology often leads to diverse healthcare careers, with many students considering advanced nursing roles. For those interested in Nurse Practitioner programs, understanding the various pathways is crucial. For example, if you're seeking the most straightforward route to becoming a Family Nurse Practitioner, you might want to look into the easiest fnp program options available online.

Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are another popular choice for immunology students who want to combine mental health with clinical practice. When selecting a program, it’s important to consider clinical placement rates, as strong placements can enhance practical skills and job prospects. You can find well-regarded options by reviewing the best pmhnp programs available.

Cost is often a key concern for many prospective students. To balance affordability with quality education, researching the most budget-friendly choices is beneficial. There are excellent options among the cheapest pmhnp programs online, which provide good value without compromising on clinical experience.

Once you complete your degree, it is natural to consider salary expectations. Understanding regional salary variations is helpful in planning your career and lifestyle. You can explore state-specific earnings by checking how much a DNP make to make informed decisions about where to work after graduation.

Best Scientists Citing Gustav Gaudernack

Trending Scientists

Recently Published Articles